SG Corporate & Investment Banking has arranged its first bond for French pharmaceutical group Sanofi-Aventis in four years. The deal is Sanofi's first since it bought Aventis for €55bn ($69.6bn) in April 2004 in Europe's largest takeover of the year.

SG last worked on a bond for the French company as joint bookrunner on a €1.25bn deal for Aventis in April 2001, and has now secured the role of sole bookrunner on the company's new bond.